Clinical Trial Update: A Phase II Study to Evaluate NH102 for Depression [Phase 2]

View source ↗

Summary

A Phase II study evaluating NH102 for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NH102

Snippet

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED